ANTHEM

Anthem Biosciences Limited

Biotechnology

Share price

₹890

Market cap

₹50,129 Cr

1Y return

▲ 17%

A biotechnology company providing contract research, development, and manufacturing services alongside specialty ingredients production. Established in 2006, the company serves pharmaceutical and nutraceutical sectors through its integrated CRDMO capabilities and custom synthesis expertise. Its distinctive position lies in combining comprehensive development expertise with in-house manufacturing facilities, enabling end-to-end solutions for clients requiring specialized ingredient formulation, process optimization, and commercial-scale production services.

Investors holding Anthem Biosciences Limited

Quant Mutual Fund

Mutual Fund

1.47%

Recent moves 27

Moves27

Viridity Tone LLP

18 Sept 2026. Sign in to see this move

Manulife Investment ManagementNew position

Manulife Investment Management bought 1,95,802 shares of Anthem Biosciences Limited for ₹14.58 Cr at ₹744.80 apiece in a block deal.

Manulife Investment ManagementNew position

Manulife Investment Management bought 14,685 shares of Anthem Biosciences Limited for ₹1.09 Cr at ₹744.80 apiece in a block deal.

Axis Mutual FundNew position

Axis Mutual Fund newly entered Anthem Biosciences, acquiring 6,686,210 shares for a 1.19% stake, worth ₹519.53 Cr at ₹777 apiece.

SBI Mutual FundNew position

SBI Mutual Fund bought 98,88,996 shares of Anthem Biosciences, representing a 1.76% stake. The acquisition was part of a larger block deal where several investors acquired a combined 3.05% stake from promoter Aruna Ganesh for ₹1,274.69 crore at ₹744.80 per share.

HDFC Mutual FundNew position

HDFC Mutual Fund entered Anthem Biosciences with 1,37,50,150 shares, a 2.44% stake worth ₹1068.76 Cr at ₹777.00 apiece. This was part of a larger transaction where promoter Aruna Ganesh sold her entire 3.05% stake in the company.

Quant Mutual FundDecreased

Quant Mutual Fund trimmed its stake in Anthem Biosciences from 1.64% to 1.47%, selling 933,851 shares for ₹72.56 Cr at ₹777.00 apiece.

Premji InvestNew position

Premji Invest bought 8,05,586 shares of Anthem Biosciences for ₹60.00 crore at ₹744.80 apiece in a block deal. This was part of a larger transaction where promoter Aruna Ganesh sold a 3.05% stake in the company and fully exited.

Aruna GaneshExited

Aruna Ganesh, a promoter, sold her entire stake of 1,71,14,604 shares of Anthem Biosciences Limited for ₹1365.92 Cr at ₹798.10 apiece in an open market transaction, exiting her 3.05% stake in the company.

Integrated Core StrategiesNew position

Integrated Core Strategies bought 10,000 shares of Anthem Biosciences Limited for ₹74.48 lakh at ₹744.80 apiece in a block deal on June 18, 2026. This was part of a larger transaction where promoter Aruna Ganesh sold a 3.05% stake in the company.

Track the whales in Anthem Biosciences Limited

Get alerted the moment a top investor buys or sells.